Y. Ashida

Combined effects of urinary plasminogen activator and tissue-type plasminogen activator in vitro and in vivo models

M. Nobuhara, Y. Horisawa, Y. Ashida, 1987 .

Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis

H. Ohnishi, H. Kosuzume, Y. Ashida, 2005, Digestive Diseases and Sciences.

[Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].

H. Ohnishi, Y. Suzuki, H. Kosuzume, 1983, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

M. Kurimoto, Masashi Kurimoto, Y. Hosaka, 1989, Japanese journal of cancer research : Gann.

CONTAMINATING SUBSTANCES IN UROKINASE PREPARATIONS

H. Ohnishi, M. Nobuhara, Y. Ashida, 1979 .

Thrombolytic Effect of Human Tissue-type Plasminogen Activator (t-PA, MMR 701) on a Canine Coronary Thrombosis Model

K. Sueishi, Kenzo Tanaka, H. Kawano, 1991 .

Thrombolytic effect of human tissue-type plasminogen activator on a canine thrombosis model

S. Shiraki, M. Nobuhara, Y. Horisawa, 1987 .

The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor.

M. Kurimoto, Y. Ashida, K. Nakayama, 1987, Japanese journal of cancer research : Gann.